drugset / Trial / NCT02141139

Perioperative Inflammation and Breast Cancer Outcome

NCT02141139

Phase 3 Unknown 1568 enrolled Samsung Medical Center
RandomizedSingle-groupOpen-labelTreatment

Summary

It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.

Timeline

Start
2014-09
Primary completion
2016-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule
Subject Ketorolac Other / unclassified Intravenous

Indications